Aprea Therapeutics (APRE) Return on Assets (2022 - 2026)
Aprea Therapeutics (APRE) posted quarterly Return on Assets of 0.02% for Q1 2026, up 1.0% year-over-year from 0.02% in Q1 2025, and up 52.84% quarter-over-quarter from 0.05% in Q4 2025.
Aprea Therapeutics (APRE) Return on Assets (2022 - 2026) Analysis & Trends
Aprea Therapeutics (APRE) has reported Return on Assets for 5 consecutive years, with 0.02% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets rose 1.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.02% (up 1.0% YoY), while the FY2025 annual figure was 0.03%, down 1.0% from the prior year.
- Return on Assets advanced to 0.02% in Q1 2026 per APRE's latest filing, from 0.05% in the prior quarter.
- Across five years, Return on Assets topped out at 0.01% in Q2 2023 and bottomed at 0.05% in Q4 2025.
- Historically, Return on Assets has averaged 0.03% across 5 years, with a median of 0.03% in 2023.
- Annual changes were most pronounced in 2023 — Return on Assets rose 2 bps — and 2024, when it declined 2 bps.
- Aprea Therapeutics' Return on Assets stood at 0.03% in 2022, then gained by 19 bps to 0.03% in 2023, then grew by 5 bps to 0.03% in 2024, then sank by 81 bps to 0.05% in 2025, then jumped by 53 bps to 0.02% in 2026.
- Business Quant data shows APRE's Return on Assets at 0.02% in Q1 2026, 0.05% in Q4 2025, and 0.04% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Aprea Therapeutics | 34.25 Mn | 34.25 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02% |
| Mar 31, 2026 | -0.02% |
| Dec 31, 2025 | -0.05% |
| Sep 30, 2025 | -0.04% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | -0.03% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.03% |
| Jun 30, 2022 | -0.02% |